Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection

Annals of Thoracic Surgery

Volumn 81, Issue 6, 2006, Pages 1974-1981

  Song, Suk Won ^a   Lee, Hyun Sung ^a   Kim, Moon Soo ^a   Lee, Jong Mog ^a   Kim, Jee Hee ^a   Nam, Byung Ho ^a   Zo, Jae Ill ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ACUTE LUNG INJURY; ADENOCARCINOMA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BRONCHOSPASM; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LOBECTOMY; LUNG CANCER; LUNG FUNCTION; LUNG INFECTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL FISTULA; BRONCHIAL SPASM; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; EMPYEMA, PLEURAL; FEMALE; FIBRINOGEN; FISTULA; HUMANS; INTRAOPERATIVE PERIOD; LIFE TABLES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL DISEASES; PNEUMONECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK; SEX FACTORS; SMOKING; SPUTUM; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33646851737     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.01.032     Document Type: Article

References (26)

1. Wang J., Olak J., Ultmann R.E., and Ferguson M.K. Assessment of pulmonary complications after lung resection. Ann Thorac Surg 67 (1999) 1444-1447
2. Hazelrigg S.R., Landreneau R.J., Boley T.M., et al. The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Carciovasc Surg 101 (1991) 394-400
3. Busch E., Verazin G., Antkowiak J.G., Driscoll D., and Takita H. Pulmonary complications in patients undergoing thoracotomy for lung resection. Chest 106 (1994) 1930-1931
4. Bolliger C.T., Jordan P., Soler M., et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med 151 (1995) 1472-1480
5. Epstein S.K., Faling L.J., Daly B.D., and Celli B.R. Inability to perform bicycle ergometry predicts increased morbidity and mortality after lung resection. Chest 107 (1995) 311-316
6. Romano P.S., and Mark D.H. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 101 (1992) 1332-1337
7. Wada H., Nakamura T., Nakamoto K., et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 115 (1998) 70-73
8. Patel R.L., Townsend E.R., and Fountain S.W. Elective pneumonectomy. factors associated with morbidity and operative mortality. Ann Thorac Surg 54 (1992) 84-88
9. Nagasaki F., Flehinger B.J., and Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 82 (1982) 25-29
10. Harpole D.H., Liptay M.J., DeCamp M.M., et al. Prospective analysis of pneumonectomy. risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 61 (1996) 977-982
11. Bagg L.R. The 12-min walking distance. its use in the preoperative assessment of patients with bronchial carcinoma before lung resection. Respiration 46 (1984) 342-345
12. Deslauriers J., Ginsberg R.J., Piantadosi S., et al. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 106 suppl (1994) 329S-330S
13. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
14. Lee H.S., Lee J.M., Kim M.S., Kim H.Y., Hwangbo B., and Zo J.I. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg 79 (2005) 405-410
15. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 83 (1991) 836-844
16. Heinrich J., Balleisen L., Schulte H., Assmann G., and Van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscleros Thromb 14 (1994) 54-59
17. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
18. Castell J.V., Gomez-Lechon M.J., David M., et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242 (1989) 237-239
19. Ernst E., and Resh K.L. Fibrinogen as a cardiovascular risk factor. a meta-analysis and review of the literature. Ann Intern Med 118 (1993) 956-963
20. Jacobson W, Park GR, Saich T, Holcroft J. Surfactant and adult respiratory distress syndrome. Br J Anaesth 70:522-6.
21. Sack Jr. G.H., Levin J., and Bell W. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasm. Medicine 56 (1977) 1-37
22. Gabazza E.C., Taguchi O., Yamakami T., Machishi M., Ibata H., and Suzuki S. Evaluating prethrombotic state in lung cancer using molecular markers. Chest 103 (1993) 196-200
23. Buccheri G., Ferrigno D., Ginardi C., and Zuliani C. Haemostatic abnormalities in lung cancer. prognostic implications. Eur J Cancer 33 (1997) 50-55
24. vanWesch J.W., and Tjwa M.K. Coagulation/fibrinolysis balance and lung cancer. Haemostasis 21 (1991) 117-123
25. Costantini V., and Zacharski L.R. Fibrin and cancer. Thromb Hemost 69 (1993) 406-414
26. Pavey S.J., Hawson G., and Marsch N.A. Alterations to the fibrinolytic enzyme system in patients with non small cell lung carcinoma. Blood Coag Fibrinol 10 (1999) 261-267